Luc Marengere - Net Worth and Insider Trading

Luc Marengere Net Worth

The estimated net worth of Luc Marengere is at least $70 Million dollars as of 2024-10-10. Luc Marengere is the Director, 10% Owner of CoLucid Pharmaceuticals Inc and owns about 1,495,386 shares of CoLucid Pharmaceuticals Inc (CLCD) stock worth over $70 Million. Details can be seen in Luc Marengere's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luc Marengere has not made any transactions after 2015-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Luc Marengere

To

Luc Marengere Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luc Marengere owns 2 companies in total, including Acer Therapeutics Inc (ACER) , and CoLucid Pharmaceuticals Inc (CLCD) .

Click here to see the complete history of Luc Marengere’s form 4 insider trades.

Insider Ownership Summary of Luc Marengere

Ticker Comapny Transaction Date Type of Owner
ACER Acer Therapeutics Inc 2017-09-19 director & 10 percent owner
CLCD CoLucid Pharmaceuticals Inc 2017-03-01 director & 10 percent owner

Luc Marengere Latest Holdings Summary

Luc Marengere currently owns a total of 1 stock. Luc Marengere owns 1,495,386 shares of CoLucid Pharmaceuticals Inc (CLCD) as of May 11, 2015, with a value of $70 Million.

Latest Holdings of Luc Marengere

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLCD CoLucid Pharmaceuticals Inc 2015-05-11 1,495,386 46.53 69,572,834

Holding Weightings of Luc Marengere


Luc Marengere Form 4 Trading Tracker

According to the SEC Form 4 filings, Luc Marengere has made a total of 0 transactions in CoLucid Pharmaceuticals Inc (CLCD) over the past 5 years. The most-recent trade in CoLucid Pharmaceuticals Inc is the acquisition of 500,000 shares on May 11, 2015, which cost Luc Marengere around $5 Million.

Insider Trading History of Luc Marengere

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luc Marengere Trading Performance

GuruFocus tracks the stock performance after each of Luc Marengere's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luc Marengere is -5.01%. GuruFocus also compares Luc Marengere's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luc Marengere within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Luc Marengere's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Luc Marengere

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Luc Marengere Ownership Network

Ownership Network List of Luc Marengere

No Data

Ownership Network Relation of Luc Marengere

Insider Network Chart

Luc Marengere Owned Company Details

What does Acer Therapeutics Inc do?

Who are the key executives at Acer Therapeutics Inc?

Luc Marengere is the director & 10 percent owner of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .

Acer Therapeutics Inc (ACER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acer Therapeutics Inc Insider Transactions

No Available Data

Luc Marengere Mailing Address

Above is the net worth, insider trading, and ownership report for Luc Marengere. You might contact Luc Marengere via mailing address: 15 New England Executive Park, Burlington Ma 01803.

Discussions on Luc Marengere

No discussions yet.